Guest post by simon@needtobreathe.co.uk t: 07917191123
Leading diverse multidisciplinary teams, building trusted relationships with partners in science, establishing working collaborations, problem solving, generating new ideas, delivering complex projects, working toward a shared vision, having an environment where people want to come and work. Strong communication sits at the core of all of these things.
I’d like to share with you a piece of research that I find immensely useful when delivering leadership or communication development programmes, it will assist anyone who is…
Guest blog post by Victoria English, Editor, MedNous, Evernow Publishing Ltd
It is often said that cell and gene therapies are a ‘process’ rather than typical drugs. This is based on the fact that their success depends on the quality of their starting materials and how they are manufactured. This could be an autologous chimeric antigen receptor (CAR) T cell-based gene therapy, or any one of the many allogeneic products in clinical development. Manufacturing is the key strategic issue for developers of these therapies, according to speakers at the On Helix annual meeting in Cambridge, UK…